Fuji Pharma Future Growth
Future criteria checks 1/6
Fuji Pharma's earnings are forecast to decline at 5.9% per annum while its annual revenue is expected to grow at 7.6% per year. EPS is expected to decline by 5.9% per annum. Return on equity is forecast to be 8.6% in 3 years.
Key information
-5.9%
Earnings growth rate
-5.9%
EPS growth rate
Pharmaceuticals earnings growth | 12.6% |
Revenue growth rate | 7.6% |
Future return on equity | 8.6% |
Analyst coverage | Low |
Last updated | 18 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2026 | 54,735 | 4,435 | 2,290 | N/A | 3 |
9/30/2025 | 50,766 | 3,971 | 1,651 | N/A | 3 |
9/30/2024 | 47,155 | 5,829 | 1,302 | N/A | 3 |
12/31/2023 | 41,639 | 5,060 | N/A | N/A | N/A |
9/30/2023 | 40,889 | 3,435 | -1,980 | 1,917 | N/A |
6/30/2023 | 38,438 | 2,036 | N/A | N/A | N/A |
3/31/2023 | 36,925 | 2,634 | -1,944 | 1,934 | N/A |
12/31/2022 | 35,976 | 2,692 | N/A | N/A | N/A |
9/30/2022 | 35,426 | 2,696 | -13,081 | -658 | N/A |
6/30/2022 | 34,962 | 2,433 | N/A | N/A | N/A |
3/31/2022 | 34,439 | 2,245 | -11,551 | 512 | N/A |
12/31/2021 | 34,141 | 2,222 | N/A | N/A | N/A |
9/30/2021 | 33,990 | 2,432 | 2,097 | 5,993 | N/A |
6/30/2021 | 34,392 | 3,161 | N/A | N/A | N/A |
3/31/2021 | 34,165 | 3,796 | 4,946 | 7,733 | N/A |
12/31/2020 | 34,120 | 2,668 | N/A | N/A | N/A |
9/30/2020 | 33,793 | 2,085 | 3,155 | 5,770 | N/A |
6/30/2020 | 33,854 | 2,006 | N/A | N/A | N/A |
3/31/2020 | 34,701 | 1,577 | 4,464 | 7,196 | N/A |
12/31/2019 | 34,968 | 2,611 | N/A | N/A | N/A |
9/30/2019 | 36,279 | 2,962 | 3,751 | 7,035 | N/A |
6/30/2019 | 37,361 | 3,287 | N/A | N/A | N/A |
3/31/2019 | 38,431 | 3,324 | 1,222 | 4,352 | N/A |
12/31/2018 | 38,231 | 3,167 | N/A | N/A | N/A |
9/30/2018 | 37,909 | 3,372 | 2,143 | 3,773 | N/A |
6/30/2018 | 37,243 | 3,219 | N/A | N/A | N/A |
3/31/2018 | 36,024 | 3,255 | 1,944 | 3,489 | N/A |
12/31/2017 | 36,412 | 3,525 | N/A | N/A | N/A |
9/30/2017 | 35,387 | 3,301 | N/A | 3,238 | N/A |
6/30/2017 | 35,217 | 3,141 | N/A | N/A | N/A |
3/31/2017 | 34,717 | 2,835 | N/A | 4,138 | N/A |
12/31/2016 | 34,234 | 2,650 | N/A | N/A | N/A |
9/30/2016 | 34,229 | 2,118 | N/A | 4,509 | N/A |
6/30/2016 | 33,708 | 2,354 | N/A | N/A | N/A |
3/31/2016 | 33,056 | 2,293 | N/A | 2,257 | N/A |
12/31/2015 | 32,540 | 2,121 | N/A | N/A | N/A |
9/30/2015 | 31,680 | 2,092 | N/A | 589 | N/A |
6/30/2015 | 31,254 | 2,030 | N/A | N/A | N/A |
3/31/2015 | 30,497 | 1,947 | N/A | 1,338 | N/A |
12/31/2014 | 30,378 | 2,051 | N/A | N/A | N/A |
9/30/2014 | 29,215 | 2,078 | N/A | 2,757 | N/A |
6/30/2014 | 28,109 | 2,094 | N/A | N/A | N/A |
3/31/2014 | 27,356 | 1,982 | N/A | 4,290 | N/A |
12/31/2013 | 26,100 | 1,999 | N/A | N/A | N/A |
9/30/2013 | 25,174 | 2,068 | N/A | 3,630 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4554's earnings are forecast to decline over the next 3 years (-5.9% per year).
Earnings vs Market: 4554's earnings are forecast to decline over the next 3 years (-5.9% per year).
High Growth Earnings: 4554's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 4554's revenue (7.6% per year) is forecast to grow faster than the JP market (4.4% per year).
High Growth Revenue: 4554's revenue (7.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4554's Return on Equity is forecast to be low in 3 years time (8.6%).